Willy Rozenbaum

18.7k total citations · 1 hit paper
169 papers, 11.0k citations indexed

About

Willy Rozenbaum is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Willy Rozenbaum has authored 169 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Infectious Diseases, 65 papers in Epidemiology and 62 papers in Virology. Recurrent topics in Willy Rozenbaum's work include HIV Research and Treatment (60 papers), HIV/AIDS drug development and treatment (52 papers) and HIV/AIDS Research and Interventions (43 papers). Willy Rozenbaum is often cited by papers focused on HIV Research and Treatment (60 papers), HIV/AIDS drug development and treatment (52 papers) and HIV/AIDS Research and Interventions (43 papers). Willy Rozenbaum collaborates with scholars based in France, United States and Canada. Willy Rozenbaum's co-authors include Luc Montagnier, Françoise Barré‐Sinoussi, C. Rouzioux, Jean‐Claude Chermann, S. Chamaret, J Gruest, M.T. Nugeyre, C. Dauguet, Shahin Gharakhanian and Christine Katlama and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Willy Rozenbaum

163 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1983 4.8k citations C. Dauguet, C. Rouzioux et al. profile →

Peers

Countries citing papers authored by Willy Rozenbaum

Since Specialization

Citations

This map shows the geographic impact of Willy Rozenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy Rozenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy Rozenbaum more than expected).

Fields of papers citing papers by Willy Rozenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willy Rozenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy Rozenbaum. The network helps show where Willy Rozenbaum may publish in the future.

Co-authorship network of co-authors of Willy Rozenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Willy Rozenbaum. A scholar is included among the top collaborators of Willy Rozenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willy Rozenbaum. Willy Rozenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proof of concept of a sexual health outreach program led by community health workers in homeless hostels in the greater Paris region 2024 ·Frontiers in Public Health ·(unknown), (unknown), (unknown), (unknown), Sylvie Le Gac, (unknown), (unknown), Jade Ghosn, Willy Rozenbaum, Élisabeth Bouvet, (unknown)	3
2	Cardiopathie ischémique silencieuse chez les patients sous ARV : prévalence et facteurs de risque 2022 ·(unknown), (unknown), Pascal Merlet, (unknown), Georgios Sidéris, Nathalie De Castro, Willy Rozenbaum, Caroline Lascoux‐Combe, Jean‐Michel Molina	1
3	Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis 2018 ·AIDS ·Marion Noret, (unknown), Claire Pintado, Martin Siguier, (unknown), Rebecca Bauer, Bénédicte Loze, A. Leplatois, Alexandre Aslan, Khafil Moudachirou, Constance Delaugerre, Willy Rozenbaum, Jean‐Michel Molina	38
4	Isolation of a New Retrovirus in a Patient at Risk for Acquired Immunodeficiency Syndrome 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·J C Chermann, (unknown), C. Dauguet, Françoise Brun‐Vézinet, C. Rouzioux, Willy Rozenbaum, Luc Montagnier	2
5	Efficacy and safety of rilpivirine‐based regimens in treatment‐experienced HIV‐1 infected patients: a prospective cohort study 2014 ·Journal of the International AIDS Society ·(unknown), Matthieu Resche‐Rigon, Jing Yang, Caroline Gatey, Anne‐Lise Munier, Kristell Desseaux, Willy Rozenbaum, Jean‐Michel Molina	3
6	Minimal interference: A basis for selecting ART for prevention with positives 2013 ·AIDS Care ·Bertrand Lebouché, Kim Engler, Joseph Josy Lévy, Norbert Gilmore, Bruno Spire, Willy Rozenbaum, Jean‐Pierre Routy	3
7	Toxicité hépatique des antirétroviraux. 2008 ·Gastroentérologie Clinique et Biologique ·G. Pialoux, Philippe Bonnard, Willy Rozenbaum	1
8	The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002 2005 ·Kidney International ·Cécile Vigneau, Jean–Baptiste Guiard–Schmid, Jérôme Tourret, Antoine Flahault, Willy Rozenbaum, Gilles Pialoux, Eric Rondeau	33
9	Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kathleen Squires, Adriano Lazzarin, (unknown), William G. Powderly, Vadim Pokrovskiy, (unknown), Joseph G. Jemsek, Antonio Rivero, Willy Rozenbaum, Shannon Schrader, Michael Sension, Asda Vibhagool, Alexandra Thiry, Michael Giordano	238
10	Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure 2004 ·Clinical Microbiology and Infection ·Véronique Schneider, Jérôme LeGoff, Laurent Bélec, Nathalie Delphin, (unknown), (unknown), Willy Rozenbaum, Jean‐Claude Nicolas	7
11	Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once‐daily for the treatment of HIV‐infected adults (pharmacokinetic substudy of the ANRS 091 trial)^* 2004 ·HIV Medicine ·Jean‐Michel Molina, Gilles Peytavin, (unknown), (unknown), D. Séréni, Willy Rozenbaum, Geneviève Chêne	32
12	Le piercing et ses complications infectieuses : Un enjeu de santé publique en France 2003 ·The Sciences ·Jean–Baptiste Guiard–Schmid, (unknown), Laurence Slama, Caroline Maslo, (unknown), Gilles Pialoux, Marie-Gisèle Lebrette, Willy Rozenbaum	0
13	Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance 2002 ·The Lancet ·(unknown), Martine Caron, Hubert Vidal, (unknown), Martine Auclair, Corinne Vigouroux, J Luboinski, Martine Laville, Mustapha Maachi, (unknown), Willy Rozenbaum, Philippe Levan, Jacqueline Capeau	325
14	Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA 2001 ·AIDS ·Nathan Clumeck, F. D. Goebel, Willy Rozenbaum, Jan Gerstoft, Schlomo Staszewski, (unknown), M Johnson, Brian Gazzard, Christopher Stone, (unknown), Sarah Moore	117
15	Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states 1997 ·Gut ·Franck Carbonnel, Laurent Beaugerie, Antoine Abou Rached, (unknown), Willy Rozenbaum, Y Le Quintrec, J P Gendre, Jacques Cosnes	28
16	Ribavirin Therapy for Adenovirus Pneumonia in an AIDS Patient 1997 ·American Journal of Respiratory and Critical Care Medicine ·Caroline Maslo, Pierre‐Marie Girard, T. Urban, (unknown), Willy Rozenbaum	19
17	Acidose lactique chez des patients infectés par le VIH. 1994 ·La Presse Médicale ·Caroline Maslo, (unknown), (unknown), (unknown), Willy Rozenbaum	4
18	Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection 1994 ·Gastroenterology ·Laurent Beaugerie, Yann Ngô, (unknown), Shahin Gharakhanian, Franck Carbonnel, J Luboinski, Michel Malafosse, Willy Rozenbaum, Y Le Quintrec	42
19	[Anasarca caused by exudative enteropathy due to digestive Kaposi's sarcoma]. 1989 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), Laurent Beaugerie, (unknown), Willy Rozenbaum, Gendre Jp, (unknown)	2
20	HIV transmission by oral sex [letter] 1988 ·The Lancet ·Willy Rozenbaum, Shahin Gharakhanian, Bernard Cardon, (unknown), (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact